Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Equity at its core: finalising the Australian Cancer Plan
The Australian Cancer Plan will unashamedly focus on equity in outcomes for Aboriginal and Torres…
Skin cancer GPs urge Barbie drug users to get checks
Experts are urging consumers or friends and relatives worried for consumers of the so-called Barbie…
COSA 2022: LGBTQI people “a growing and medically underserved population” in cancer care
Results from the largest data set of LGBTQI+ people with cancer internationally will be presented…
First patient enrolled in Australia in prostate cancer trial
- Delaying prostate cancer radiation therapy offers room for flexibility in pandemic peak
- State first MR-Linac: GenesisCare launches NSW-first adaptive radiation therapy technology for patients with prostate and oligometastatic cancer
- Acute exercise has beneficial effects on the immune system during prostate cancer
Researchers restore fertility in non-human primate model of childhood cancer survivorship
One in three childhood cancer survivors is at risk of becoming infertile due to chemotherapy or radiation, and since their…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.